Search

everythinglearnresearchcommunity

for

Search:↓

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Women with thinning hair have thinner hair strands than women without hair loss.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Androgens can both increase body hair and cause scalp hair loss.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.